Terms: = Liver cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Prognosis
43 results:
1. Tissue Circular RNA_0004018 and 0003570 as Novel Prognostic Biomarkers for Hepatitis B-Related Hepatocellular Carcinoma.
Kang MK; Kim G; Park JG; Jang SY; Lee HW; Tak WY; Kweon YO; Park SY; Lee YR; Hur K
Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895312
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study.
Huang J; Wang ZG; Tao QF; Yang Y; Yuan SX; Gu FM; Liu H; Pan ZY; Jiang BG; Lau WY; Zhou WP
Front Immunol; 2023; 14():1198562. PubMed ID: 37483609
[TBL] [Abstract] [Full Text] [Related]
4. A case report of pulmonary hepatoid adenocarcinoma: promoting standardized diagnosis and treatment of the rare disease.
Xu K; Gao J; Feng L; Fang Y; Tang X
Front Immunol; 2023; 14():1203876. PubMed ID: 37292208
[TBL] [Abstract] [Full Text] [Related]
5. [Association between HULC gene locus rs7763881 polymorphism and recurrence and metastasis after radical resection in hepatocellular carcinoma].
Qi XF; Sun DJ; Ye XZ; Xu BQ; Wei ZH; Li HT
Zhonghua Gan Zang Bing Za Zhi; 2023 Mar; 31(3):281-287. PubMed ID: 37137854
[No Abstract] [Full Text] [Related]
6. Risk Factors of Positive Resection Margin in Hepatectomy for Resectable Ruptured Hepatocellular Carcinoma: Risk Prediction and prognosis.
Xia F; Zhang Q; Zheng J; Huang Z; Ndhlovu E; Gao H
J Gastrointest Surg; 2023 Jul; 27(7):1400-1411. PubMed ID: 37095336
[TBL] [Abstract] [Full Text] [Related]
7. Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study.
Meng Q; Zhao J; Yu Y; Wang K; Ren J; Xu C; Wang Y; Wang G
BMC Cancer; 2023 Feb; 23(1):191. PubMed ID: 36849918
[TBL] [Abstract] [Full Text] [Related]
8. Contrast-Enhanced CT Imaging Features Combined with Clinical Factors to Predict the Efficacy and prognosis for Transarterial Chemoembolization of Hepatocellular Carcinoma.
Sun Z; Shi Z; Xin Y; Zhao S; Jiang H; Li J; Li J; Jiang H
Acad Radiol; 2023 Sep; 30 Suppl 1():S81-S91. PubMed ID: 36803649
[TBL] [Abstract] [Full Text] [Related]
9. Efficacy and safety of no-touch radiofrequency ablation for small hepatocellular carcinoma-a systematic review and single-arm meta-analysis.
Du F; Zhang L; Zhang Y; Fan H; Ren L
Clin Res Hepatol Gastroenterol; 2023 Jan; 47(1):102069. PubMed ID: 36513251
[TBL] [Abstract] [Full Text] [Related]
10. Changes in Body Composition Predict the Time to Treatment Failure of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma: A Pilot Retrospective Study.
Yamamoto T; Imai N; Kuzuya T; Yokoyama S; Yamamoto K; Ito T; Ishizu Y; Honda T; Ishigami M
Nutr Cancer; 2022; 74(9):3118-3127. PubMed ID: 35285364
[TBL] [Abstract] [Full Text] [Related]
11. Nontumor related risk score: A new tool to improve prediction of prognosis after hepatectomy for colorectal liver metastases.
Sasaki K; Margonis GA; Moro A; Wang J; Wagner D; Gagnière J; Shin JK; D'Silva M; Sahara K; Miyata T; Kusakabe J; Beyer K; Dupré A; Kamphues C; Imai K; Baba H; Endo I; Taura K; Cho JY; Aucejo F; Kornprat P; Kreis ME; Kim JM; Burkhart R; David Kwon CH; Pawlik TM
Surgery; 2022 Jun; 171(6):1580-1587. PubMed ID: 35221105
[TBL] [Abstract] [Full Text] [Related]
12. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
Izquierdo-Sanchez L; Lamarca A; La Casta A; Buettner S; Utpatel K; Klümpen HJ; Adeva J; Vogel A; Lleo A; Fabris L; Ponz-Sarvise M; Brustia R; Cardinale V; Braconi C; Vidili G; Jamieson NB; Macias RI; Jonas JP; Marzioni M; Hołówko W; Folseraas T; Kupčinskas J; Sparchez Z; Krawczyk M; Krupa Ł; Scripcariu V; Grazi GL; Landa-Magdalena A; Ijzermans JN; Evert K; Erdmann JI; López-López F; Saborowski A; Scheiter A; Santos-Laso A; Carpino G; Andersen JB; Marin JJ; Alvaro D; Bujanda L; Forner A; Valle JW; Koerkamp BG; Banales JM
J Hepatol; 2022 May; 76(5):1109-1121. PubMed ID: 35167909
[TBL] [Abstract] [Full Text] [Related]
13. Impact of psoas muscle index assessed by a simple measurement method on tolerability and duration of continued treatment with sorafenib in hepatocellular carcinoma patients.
Ogushi K; Chuma M; Numata K; Nozaki A; Moriya S; Uojima H; Kondo M; Morimoto M; Maeda S
Eur J Gastroenterol Hepatol; 2022 Jul; 34(7):774-781. PubMed ID: 35102114
[TBL] [Abstract] [Full Text] [Related]
14. [Clinical observation of palbociclib combined with endocrine therapy in hormone receptor positive and HER2 negative advanced breast cancer].
Lyu HM; Niu LM; Zhang MW; Zeng HA; Zhao SN; Liu ZZ; Yan M
Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(44):3625-3630. PubMed ID: 34823278
[No Abstract] [Full Text] [Related]
15. Prolonged survival in patients with hand-foot skin reaction secondary to cooperative sorafenib treatment.
Ochi M; Kamoshida T; Araki M; Ikegami T
World J Gastroenterol; 2021 Aug; 27(32):5424-5437. PubMed ID: 34539142
[TBL] [Abstract] [Full Text] [Related]
16. Pulmonary infection after hepatic resection: Associated factors and impact on outcomes.
Loncar Y; Tartrat N; Lastennet D; Lemoine L; Vaillant JC; Savier E; Scatton O; Granger B; Eyraud D
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101733. PubMed ID: 34146724
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathologic features of metastatic small cell carcinoma of the prostate to the liver: a series of four cases.
Bell PD; Huber AR; Agostini-Vulaj D
Diagn Pathol; 2021 Apr; 16(1):35. PubMed ID: 33892760
[TBL] [Abstract] [Full Text] [Related]
18. Association of albumin-bilirubin score in patients with colorectal cancer receiving later-line chemotherapy with regorafenib.
Watanabe D; Fujii H; Yamada Y; Matsuhashi N; Makiyama A; Iihara H; Takahashi T; Kiyama S; Kobayashi R; Yoshida K; Suzuki A
Int J Clin Oncol; 2021 Jul; 26(7):1257-1263. PubMed ID: 33839963
[TBL] [Abstract] [Full Text] [Related]
19. Serum Laminin γ2 Monomer as a Diagnostic and Predictive Biomarker for Hepatocellular Carcinoma.
Yamashita T; Koshikawa N; Shimakami T; Terashima T; Nakagawa M; Nio K; Horii R; Iida N; Kawaguchi K; Arai K; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kitao A; Kobayashi S; Takahara S; Imai Y; Yoshimura K; Murayama T; Nakamoto Y; Yoshida E; Yoshimura T; Seiki M; Kaneko S
Hepatology; 2021 Aug; 74(2):760-775. PubMed ID: 33609304
[TBL] [Abstract] [Full Text] [Related]
20. Long-term Outcomes and Factors Affecting the Survival of Patients with Mucosal Esophageal Squamous Cell Carcinoma.
Kim GH; Na HK; Ahn JY; Lee JH; Jung KW; Kim DH; Kim HR; Choi KD; Song HJ; Kim YH; Lee GH; Jung HY; Park SI
Gut Liver; 2021 Sep; 15(5):705-712. PubMed ID: 33462160
[TBL] [Abstract] [Full Text] [Related]
[Next]
